Cargando…
Morphea: progress to date and the road ahead
Morphea is a rare autoimmune condition causing inflammation and sclerosis of the skin and underlying soft tissue. It is characterized by periods of activity (inflammation admixed with fibrosis), ultimately resulting in permanent damage (pigment change and tissue loss). Damage resulting from unchecke...
Autores principales: | Abbas, Laila, Joseph, Adrienne, Kunzler, Elaine, Jacobe, Heidi T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033330/ https://www.ncbi.nlm.nih.gov/pubmed/33842658 http://dx.doi.org/10.21037/atm-20-6222 |
Ejemplares similares
-
AB012. Clinical and demographic features of morphea patients with mucocutaneous involvement: a cross sectional study from the morphea of adults and children (MAC cohort)
por: Prasad, Smriti, et al.
Publicado: (2021) -
AB007. Worse skin disease severity may distinguish patients who progress from cutaneous lupus erythematous to systemic lupus erythematous
por: Walocko, Frances, et al.
Publicado: (2021) -
AB014. Developing classification criteria for skin-predominant dermatomyositis: assessing the methodology of the prospective validation study
por: Concha, Josef Symon S., et al.
Publicado: (2021) -
AB017. Increased dendritic cells and IFN-beta and MxA protein expression in spongiotic dermatitis differentiates dermatomyositis from eczema
por: Zeidi, Majid, et al.
Publicado: (2021) -
AB020. A case report on cutaneous necrotizing vasculitis treated with colchicine in a Filipino adult male
por: Cruz, Luisa Marie S., et al.
Publicado: (2021)